Clinical Trials Directory

Trials / Completed

CompletedNCT04699617

The Feasibility and Efficacy of an Immersive Virtual Reality Software in Parkinson's Disease Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Campus Neurológico Sénior · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Dolphin 2.0 is a platform that runs an immersive virtual reality software, based on an oceanic environment, where players control simulated creatures (dolphin, orca, axolotl). Video games lead to high levels of motivation and arousal, provide immediate feedback and playback, provide explicit reward and implicit success, and titrate difficulty levels. This encourages the practice of exercise, being an important complement to physiotherapy sessions. The main goal of this study is to evaluate the feasibility, safety and efficacy of an immersive virtual reality software (Dolphin, 2.0) in Parkinson's disease symptomatic control, in a two-arm, randomized, single-blind (blind rater for primary and secondary outcomes), delayed-start feasibility and efficacy trial.

Conditions

Interventions

TypeNameDescription
DEVICEDolphin 2.0The Dolphin 2.0 is a platform that runs an immersive virtual reality software, based on an oceanic environment, where players control simulated creatures.

Timeline

Start date
2020-12-28
Primary completion
2022-02-28
Completion
2022-02-28
First posted
2021-01-07
Last updated
2023-08-16

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT04699617. Inclusion in this directory is not an endorsement.

The Feasibility and Efficacy of an Immersive Virtual Reality Software in Parkinson's Disease Patients (NCT04699617) · Clinical Trials Directory